Sexual Desire and Pharmacologic Management

Authors

Tami S. Rowen, Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA. Electronic address: Tami.Rowen@ucsf.edu.
James A. Simon, Obstetrics & Gynecology, George Washington University, Washington, DC, USA.

Document Type

Journal Article

Publication Date

6-1-2024

Journal

Obstetrics and gynecology clinics of North America

Volume

51

Issue

2

DOI

10.1016/j.ogc.2024.03.004

Keywords

Hormones; Hypoactive sexual desire; Low libido; Neurotransmitters and sexual health

Abstract

Female sexual desire is a complex interplay of neurotransmitters and hormones. Diagnosis is based on clinical features and sexual distress. Treatments that affect neurotransmitters and hormones that may be out of balance can help improve sexual desire in women with hypoactive sexual desire disorder.

APA Citation

Rowen, Tami S. and Simon, James A., "Sexual Desire and Pharmacologic Management" (2024). GW Authored Works. Paper 5186.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/5186

Department

Obstetrics and Gynecology